Max CV IIi 09

CURICULUM VITAE summary

MAXWELL EDMUND WHISSON

Personal: Born 7th December 1930 in Melbourne.Educated Lilydale and Box Hill High Schools. Married. Wife Swiss. Six children.

Early employment:Truck & ambulance driver Upper Yarra Dam Apprentice sheet metal worker C’wealth Aircraft Corp.

University: University of Melbourne.

Medical School: Royal Melbourne Hospital.

Qualifications: M.B.,B.S. 1955, MRCPath, 1978., FRCPath, 1990

Registration: Victoria 1956, London 1966, New Zealand 1979, WA 1980-.

General PracticeVarious Locums in Melbourne 1956 - 1957Oakhill Clinic (Melb., part-time) 1957 - 1960Hospital AppointmentsBendigo Base H. (RMO, RSO) 1956Box Hill & District H. (RMO, RSO & 1/12 Acting Med. Superintendant) 1957Royal Children’s H. (RMO, RSO ) 1957Royal Melbourne H. (Hon. Assistant Med. OP) 1957 - 1960Royal Marsden H., London (Gordon Jacobs Research Fellow)

1963 - 1964St. George’s H., London (Resident Clinical Pathologist)

1971 - 1972

Basildon & Orsett (Sth. Essex AHA) (Registrar Haematology)1972 -

1974Bournemth, Southampton, Wessex RTC (Hampshire AHA) Sen. Registrar 1974 - 1978Poole Gen. H., Central Middlesex H., Sth. Essex.1/12 Consultant Locums1975 - 1979Manwatu (NZ) Specialist Haematologist, Regional Transfusion Officer 1979 - 1980Clinical Assistant Princess Margaret & sometime Acting Consultant Haem.1982 - 1986Clincal Assistant Royal Perth Hospital 1981 - 1997Deputy Director & Clinic haematologist 1980 - 1990Director R&D ARC Blood TS (WA) & occasional Acting Director

1990 - 1998

University & Research AppointmentsUniversity of Melbourne: Tutor, Research Fellow in Pharmacology 1959 - 1962University of London: Lecturer, Biochem. Pharmacol.

1965 - 1968Inst. Cancer Research (Lond.) Head. Experimental Chemotherapy Unit. 1965 - 1968University of London: Lecturer Cell Biology 1969 - 1970Inst. Cancer Research (Lond.) Head. Experimental BiotherapyUnit. 1969 - 1970Anti-Cancer Coucil of Victoria (Inst. Cancer Res., London) Trav. Fellow 1962 - 1964WHO, Inst. Cancer Res.Bratislava, Slovakia, Research Fellow

1970Centre for Immunology & Instrumentation, UWA, Perth. Dep. Chairman 1999 - 1999

2

The Gray Lab., Mt Vernon, London. Visiting Research Fellow1997 -

1999

Committees (selected list)Transfusion Advisary C. (NZ) iand Subcomittees on Plasma Recovery & on Computerisation in Transfusion 1979 - 1980AIDS Advisary Committee (HDWA) 1985 - 1996First National committees on AIDS (Pennington, Penny)

1984 - 1985Unrelated Bone Marrow Transplant Registry (inaugural setup meetings) 1985 - 1987Trnafusion Advisary Committees (Fremantle H., King Edward Memorial H.1984 - 1997

3

Memberships (selected list)ASBTHSAISBTASCIA (Clinical Immunology & Allergy)UMMS (University of Melbourne Medical Society)University of Melbourne AlumniiWyvern (Queen’s College, Melb.)Australian Scientific Industry Association (1985 - 1992)

Grants Awarded (selected list , & see “research appointments” above).MEDWA (for safe injection Devices) 1991 - 1992NH&MRC Project Grant (2y.) 1991 - 1992 NH&MRC Development Grant (2y.) 1994 - 1996

Memorable Teachers, Supervisors & ColleaguesSir Edward DunlopSir Alexander HaddowSir Macfarlane BurnetProf. R.D. (Pansy) WrightProf. Ray BradleyProf John Coghlan

Current Appointments

Second Violin, Fremantle Symphony Orchestra 1988 - Chairman, Board of Directors Eastland Technology, 1990 - 1999Centre for Immunology & Instrumentation, UWA, Perth. Dep. Secretary 1999 -Director, Water UN Limited, 2nd Fl, 7 Havelock Street, W. Perth, WA 6005 2003-

4

PUBLICATIONS

REFEREED PAPERS

2011

M.Whisson. Wind Power and Ecology, Nature and Society

Oct-Nov-2011.7–9. <www.natsoc.org.au >

2008

M. Whisson Two Proposals for Unlimited fresh water. Int J. Environmental Issues, Vol 3, No. 3, 224- 223, 2008

1997

Guppy, M., Abas, L., Neylon, C., Whisson, M.E., Pethick,

D.W. and Niu, X-W. (1997) Fuel choices by human

platelets in human plasma. Eur. J. Biochem. 244, 161-

167.

Niu, X-W, Whisson, M.E. and Guppy, M. (1997) Types and

sources of fuels for platelets in a medium containing

minimal added fuels and a low carryover plasma. Brit. J.

Haem. 97, 908-916.

Whisson, M.E. and Cheng, A. (1997) Recovery of extra

plasma during preparation of platelet concentrates using

a new centrifugation support. Trans. Med. 7 : 203-9.

1996

5

http://www.natsoc.org.au/

Niu, X-W., Arthur, P., Abas, L., Whisson, M. and Guppy,

M. (1996) Carbohydrate metabolism in human platelets in

a low glucose medium under aerobic conditions. Biochem.

Biophys. Acta. 1291, 97-106.

1995

Guppy, M., Abas, L., Arthur P.G. and Whisson, M.E.

(1995) The Pasteur effect in human platelets:

implications for storage and metabolic control. B. J.

Haem. 91, 752-757.

Guppy, M., Whisson, M.E., McConnell, M. and Abas, L.

(1995) A complete platelet system for metabolic studies:

pure, defined, and viable over 8 hours. Anal. Biochem.

226(1), 113-119.

1993

Whisson, M.E., Nakhoul, A., Howman, P., Niu, X. and

Guppy, M. (1993) Quantitative study of starving

platelets in a minimal medium: maintenance by acetate or

plasma but not by glucose. Trans. Med. 3, 101-113.

1992

Guppy, M., Attwood, P.V., Hansen, I.A., Sabaratnam, R.,

Frisina, J. and Whisson, M.E. (1992) pH, temperature and

6

lactate production in human red blood cells: implications

for blood storage and glycolytic control. Vox Sang. 62,

70-75.

Guppy, M., Whisson, M.E., Sabaratnam, R., Niu, X-W. and

Britto, J. (1992) Evaluation of the trisodium salt of 3-

phosphoglycerate as a fuel for red cell storage.

Comparative Haematology International. 2, 35-43.

Niu, X., Whisson, M.E., Rossetto, M. and Guppy, M. (1992)

A simple and effective method for producing purified,

resting platelets for metabolic studies. Comparative

Haematology International. 2, 106-110.

1990

Guppy, M., Sabaratnam, R., Devadason, S. and Whisson, M.

(1990) Fructose formation in stored blood. Biochem.

Intl. 21(2), 219-224.

Guppy, M., Sabaratnam, R. and Whisson, M. (1990)

Temperature and red cell metabolism: effects of -stat

and pH-stat conditions. J. therm. Biol. 15(2), 115-118.

Guppy, M., Whisson, M.E., Sabaratnam, R., Withers, P. and

Brand, K. (1990) Alternative fuels for platelet storage:

a metabolic study. Vox Sang. 59, 146-152.

7

Surveyor, I. Mullan, B.P., Barr, A.L., Cannell, P.K.,

Lill, M.C.C. and Whisson, M.E. (1990) Images before and

after splenectomy showing the distribution of homologous

In111 platelets in a case of immune thrombocytopenic

purpura Clin. Nuclear Med. 15(11), 850-852.

1985

Williamson, D., Whisson, M.E., Whineray, M., Wells,

R.M.G., Brennan, S.O. and Carrell, R.W. (1985)

Polycythaemia associated with a new haemoglobin variant:

haemoglobin Palmerston North beta 23 (B5) valphe. NZ

Med. J. 98(783), 585-587.

1982

Brennan, S.O., Williamson, D., Whisson, M.E. and Carrell,

R.W. (1982) Hemoglobin Palmerston North 23 (B5)

valphe. A new variant identified in a patient with

polycythemia. Hemoglobin. 6(6), 569-575.

1977

Smith, J.L., Gordon, J. Newell, D.G. and Whisson, M.

(1977) The biosynthesis and characterisation of

unreleased lgM in a case of CLL. Brit. J. Haem. 37,

217-222.

8

1973

Szekerke, M. , Wade, R., Whisson, M.E. (1973) The use of

macromolecules as carriers of cytotoxic groups. (Part

III). Synthesis and characterisation of polypeptidyl-

fibronogen derivatives. Neoplasma. 20(2), 163-169.

1972

Szekerke, M. , Wade, R., Whisson, M.E. (1972) The use of

macromolecules as carriers of cytotoxic groups (Part I).

Conjugates of nitrogen mustards with proteins,

polypeptidyl proteins and polypeptides. Neoplasma.

19(3), 199-209.

Szekerke, M. , Wade, R., and Whisson, M.E. (1972) The

use of macromolecules as carriers of cytotoxic groups

(Part II). Nitrogen mustard - protein complexes.

Neoplasma. 19(3), 211-215.

Whisson, M.E. (1972) The plasmagene deletion theory and

the appearance of ‘new’ gene products. Cell

Differentiation. Harris, R., Allin, P.and Viza, D.

(Eds.): Munksgaard, 138-143.

1970

Whisson, M.E. (1970) Cytoplasmic inheritance in metazoa

9

and its relationship to cell phenotype. I. Hypothesis.

Neoplasma. 17(5), 451-462.

Whisson, M.E. (1970) Cytoplasmic inheritance in metazoa

and its relationship to cell phenotype. II. Preliminary

experiments on the effect of cytoplasmic particles on

ascites tumour cells. Neoplasma. 17(5), 463-474.

Whisson, M.E. and Connors, T.A. (1970) Cytotoxic drugs.

Scientific Foundations of Obstetrics and Gynaecology.

Philipp, E.E. (Ed.): Heinemann, London.

Whisson, M.E., Ujhazy, V., Krempasky, V. and Bohunicka,

E. (1970) Cytoplasmic inheritance in metazoa and its

relationship to cell phenotype. III. Uptake of mouse

liver cell fractions by 6C3HED lymphosarcoma cells in vitro.

Neoplasma. 17(6), 579-586.

1969

Cobb, L.M., Connors, T.A., Elson, L.A., Khan, A.H.,

Mitchley, B.C., Ross, W.C. and Whisson, M.E. (1969) 2.4-

dinitro-5-ethyleneimino-benzamide (CB 1954): a potent and

selective inhibitor of the growth of the Walker carcinoma

256. Biochem. Pharmacol. 18(6), 1519-1527.

Whisson, M.E. and Siracky, J. (1969) Increased

sensitivity of a plasma cell tumour to T.E.M. on

10

conversion to the ascitic form: relationship to karyotype

and cycle kinetics. Neoplasma. 16(4), 347-427.

1968

Jeney, A., Connors, T.A., Whisson, M.E. and Warwick, G.P.

(1968) Aromas mustarnitrogenik hatas mechaniz - musarak

tanulmanyozasa (Researches on the mechanism of action of

aromatic nitrogen mustard compounds). Kiserl. Orvostud.

20, 369-375.

1967

Wade, R., Whisson, M.E. and Szekerke, M. (1967) Some

serum protein nitrogen mustard complexes with high

chemotherapeutic selectivity. Nature. 215(5107), 1303-

1304.

Whisson, M.E. (1967) The interaction of tumour and

embryonic tissue in vivo. Ciba Foundation Symposium on Cell

Differentiation. de Reuck, A.S.V. and Knight J. (Eds.):

Churchill, London, 219-230.

1966

Ball, C.R., Connors, T.A., Double, J.A., Whisson, M.E.

and Ujhazy, V. (1966) Comparison of nitrogen-mustard-

sensitive and resistant Yoshida sarcomas. Int. J.

11

Cancer. 1, 319-327.

Connors, T.A. and Whisson, M.E. (1966) Cure of mice

bearing advanced plasma cell tumours with aniline

mustard: the relationship between glucoronidase activity

and tumour sensitivity. Nature. 210(5038), 866-867.

Goldacre, R.J. and Whisson, M.E. (1966) The biology of

large solid tumours regressing with nitrogen mustard

treatment: a study of the mouse plasma-cell tumour Adj-

pc5 and the Walker carcinosarcoma 256. Brit. J. Cancer.

20(4), 801-812.

Whisson, M.E., Connors, T.A. and Jeney, A. (1966)

Mechanism of cure of large plasma cell tumours. Archivum

lmmunologiae et Therapiae Expenmentalis. 14(6), 825-831.

1965

Connors, T.A., Jeney, A.. and Whisson, M.E. (1965)

Reduction in the toxicity of radiomimetic alkylating

agents in rats by thiol pretreatment. V. The effect of

thiol pretreatment on the anti-tumour action of Merophan.

Biochem. Pharmacol. 14, 1681-1683.

Whisson, M.E. and Connors, T.A. (1965) Drug-induced

regression of large plasma cell tumours. Nature.

205(4969), 406.

12

Whisson, M.E. and Connors, T.A. (1965) Cure of mice

bearing advanced plasma cell tumours with aniline

mustard. Nature. 206(4985), 689-691.

Connors, T.A., Rosenoer, V.M., Whisson, M.E., Jeney, A.

and Warwick, G.P. (1965) Some factors influencing the

sensitivity of tumours to nitrogen mustard. Isotopes in

Experimental Pharmacology Roth, L.J. (Ed.): University

of Chicago Press, 433-438.

1964

Rosenoer, V.M. and Whisson, M.E. (1964) A transplantable

plasma cell tumour in the study of carcinostatic agents.

Biochem. Pharmacol. 13, 589-602.

1963

Whisson, M.E., Rosenoer, V.M. and Topping, N.E. (1963)

Dilution anaemia in mice bearing transplanted tumours.

B.E.C.C. Report. Part II, 111.

13

INVITED SPEAKER

1996

Whisson, M. Development of a new bag set with glucose-

free primary anticoagulant and platelet additive. 24th

ISBT. Makuhari, Japan. March 1996.

1995

Whisson, M.E. Ideal and practical preparation of red

blood cells for thalassaemia support: closed system

filtered red cells. First Conference on Thalassaemia.

Perth, Australia. August, 1995.

1994

Whisson, M. Developments in the preparation of

platelets. Joint meeting of the ASBT and HSA. Perth,

Australia. October 1994.

1990

Guppy, M., Attwood, P.V., and Whisson, M.E. red cell

storage: what is the right pH? Joint meeting of the HSA,

ASBT, NZSH and RCPA. Christchurch, New Zealand. October

1990.

14

Whisson, M.E., Guppy, M., Rosetto, M. and Niu, X-W.

Platelet metabolism and storage: “no added sugar”. Joint

meeting of the HSA, HSA, NZSH and RCPA. Christchurch,

New Zealand. October 1990.

15

1972

Whisson M.E. The plasmagene deletion theory and the

appearance of 'new' gene products. Proceedings of the

First International Conference on Cell Differentiation.

Nice, France. 1972.

PUBLISHED ABSTRACTS

1997

Whisson, M.E. and Cheng, A. (1997) Plasma recovery with

the ‘second spin’ technique: problems solved (Abstract A19).

Trans. Med. 7(2), 149-150.

Whisson, M.E., Cheng, A. and Guppy, M. (1997) Evidence

for a plasma factor for platelet maintenance (Abstract A23).

Trans. Med. 7(2), 151.

Boyd, S., Cobain, T.J., Simpson, M.C. and Whisson, M.E.

(1997) Increased plasma yield from platelet production -

implementation and outcomes (Abstract A24).. Trans. Med.

7(2), 151.

1996

16

Whisson, M., Cheng, A. and Flanigan, J. (1996).

Changes in the platelet pellet during the ‘hanging’

period (Abstract SY2DI-03). Vox Sang. 70(S2), 22.

Whisson, M., Howman, P. and Cheng, A. (1996) Development

of the ‘second spin’ technique to improve plasma recovery

(Abstract 1/2F-53P). Vox Sang. 70(S2), 126.

Whisson, M., Cheng, A. and Guppy, M. The significance

of small amounts of residual plasma in evaluating

platelet additive solutions (Abstract 1/2F-55P). Vox Sang.

70(S2), 126.

1995

Whisson, M. Transfusion of the fetus and neonate: a

neglected area (Abstract A14). Trans. Med. 5(1), 78.

1994

Whisson, M., Howman, P., Nakhoul, A-M., Simpson, M. and

Cobain, T. Each platelet bag costs 123ml of plasma: a

second spin could save 64ml. (Abstract A36). Trans. Med.

4(1), 80.

17

Whisson, M., Howman, P., Nakhoul, A-M. (1994) Caramel,

the bogey of the blood bag manufacturer, may be

beneficial (Abstract A57). Trans. Med. 4(1), 86.

Whisson, M., Nakhoul, A-M., Howman, P., Niu, X. and

Guppy, M. (1994) First demonstration of prolongation of

platelet storage by glucose - but is it necessary? (Abstract

A33). Trans. Med. 4(1), 79-80.

1993

Dunmow, R., Wilson, D. and Whisson, M. (1993) A modified

method for detecting high titre anti-A and anti-B in

group O donors (Abstract A6). Trans. Med. 3(1), 72.

Guppy, M., Haig, C., Howman, P. and Nakhoul, A-M. (1993)

The energy metabolism of circulating cells (Abstract A26).

Trans. Med. 3(1), 77.

Whisson, M., Howman, P., Nakhoul, A-M. and Guppy, M.

(1993). Acetate utilisation rates and the effect of

glucose-free plasma in platelet concentrate stored in

minimal medium (MPM) (Abstract A27). Trans. Med. 3(1), 77.


(A44) Facts and fantasy in the development of platelet

additive solutions (Abstract A27). Trans. Med. 3(1), 82.

18

Fisher, B., Whisson, M., Cobain, T. and Wyatt, C. Donor

IgM anti-A with haemolytic transfusion reaction (1993)

(Abstract A78). Trans. Med. 3(1), 90.

1992

Whisson, M.E. (1992) Safe parenteral device design:

basic principles of design and manufacture (Abstract S16).

Trans. Med. 2(2), 165.

Howman, P. and Whisson, M. (1992) Use of foreign blood

packs and giving sets: a study in incompatibility and a

call for standardisation (Abstract S17). Trans. Med. 2(2),

165.

Howman, P. and Whisson, M.E. (1992) Closed system red

cell filtering technique allows platelet recovery and use

of banked units (Abstract S21). Trans. Med. 2(2), 166.

Whisson M.E., Nakhoul, A., Howman, P., and Guppy, M.

(1992) Platelet storage study using a new plasma-free

‘starvation medium’ and new objective ‘swirl’ assay

(Abstract S22). Trans. Med. 2(2), 166.

1991

19

Guppy, M., Attwood, P.V., and Whisson, M.E. (1990) Red

cell storage: what is the right pH? (Abstract S17). Trans.

Med. 1(2), 137.


(1990) Platelet metabolism and storage: “no added sugar”

(Abstract S20). Trans. Med. 1(2), 138.

Whisson, M.E., Simpson, M. and Handley, P. (1990)

Improved donor care with the ‘ZPR’: a one year study

(Abstract P5). Trans. Med. 1(2), 142.

20

ABSTRACTS

1997

Lazzaro, G.E., Simpson, M.C., Wilson, D., Cheng, A. and

Cobain, T.J. An absolute counting technique for the

enumeration of low numbers of white cells in

leukodepleted blood products using TRUCOUNTTM Submitted

for 1997 joint meeting of the ASBT, HSA and MOGA.

Auckland, New Zealand.

Lazzaro, G.E., Simpson, M.C., Wilson, D., Cheng, A. and

Cobain, T.J. An absolute counting technique for the

enumeration of low numbers of white cells in

leukodepleted blood products using TRUCOUNTTM Joint

meeting of the ASBT (WA) and HSA (WA). Margaret River,

Australia. May 1997. (Oral presentation).

1996

Whisson, M.E., Cheng, A. and Guppy, M. Evidence for a

new plasma factor for platelet maintenance. Joint

meeting of the ASBT (WA) and HSA (WA). Margaret River,

Australia. May 1996. (Oral presentation).

Whisson, M. Development of a new bag set with glucose-

free primary anticoagulant and platelet additive. 24th

21

ISBT. Makuhari, Japan. March 1996. (Oral

presentation).

Whisson, M., Howman, P. and Cheng, A. Development of the

‘second spin’ technique to improve plasma recovery. 24th

ISBT. Makuhari, Japan. March 1996. (Poster

presentation).

Whisson, M., Cheng, A. and Guppy, M. The significance

of small amounts of residual plasma in evaluating

platelet additive solutions. 24th ISBT. Makuhari,

Japan. March 1996. (Poster presentation).

Whisson, M.E. and Cheng, A. Plasma recovery with the

‘second spin’ technique: problems solved. Joint meeting

of the ASBT, HSA and MOGA. Adelaide, Australia. October

1996. (Oral presentation).

Whisson, M.E., Cheng, A. and Guppy, M. Evidence for a

plasma factor for platelet maintenance. Joint meeting of

the ASBT, HSA and MOGA. Adelaide, Australia. October


Boyd, S., Cobain, T.J., Simpson, M.C. and Whisson, M.E.

Increased plasma yield from platelet production -

implementation and outcomes. Joint meeting of the ASBT,

HSA and MOGA. Adelaide, Australia. October 1996. (Oral

presentation).

22

Whisson, M.E., Cheng, A. and Guppy, M. Is sodium

nitroprusside a suitable and cheap source of nitric oxide

to improve PC preparation from PRP? Joint meeting of the

ASBT, HSA and MOGA. Adelaide, Australia. October 1996.

(Poster presentation).

Whisson, M.E., Cheng, A., Flanigan, J. and Guppy, M.

Prospects for minimising changes in the platelet pellet

during the ‘hanging’ period. Joint meeting of the ASBT,

HSA and MOGA. Adelaide, Australia. October 1996.


1995

Whisson, M., Howman, P., Cheng, A. and Guppy, M. The

platelet pellet: a hostile environment. Joint meeting of

the ISH (Asia Pacific), HSA and ASBT. Brisbane,

Queensland. October, 1995. (Poster presentation).

Boyd, S., Cobain, T.J. and Whisson, M. The production of

autologous fibrin glue. Joint meeting of the ISH (Asia

Pacific), HSA and ASBT. Brisbane, Queensland. October,

1995. (Poster presentation).

1994

23

Guppy, M., Whisson, M.E., McConnel, M., Neylon, C. and

Abas, L. A preparation of pure, quantitated and viable

human platelets: in vivo energy budget and the Pasteur

effect. Combined Biological Sciences Meeting. Perth,

Australia.

Whisson, M. Developments in the preparation of

platelets. Joint meeting of the ASBT and HSA. Perth,

Australia. October 1994. (Oral presentation).

Guppy, M., Whisson, M.E., McConnel, M., Neylon, C. and

Abas, L. In vivo platelet metabolism and the effects of

hypoxia studied using purified platelets in citrated

autologous plasma. . Joint meeting of the ASBT and HSA.

Perth, Australia. October 1994. (Oral presentation).

Whisson, M. Transfusion of the fetus and neonate: a

neglected area. Joint meeting of the ASBT and HSA.

Perth, Australia. October 1994. (Poster presentation).

Guppy, M., Whisson, M.E., McConnel, M, Neylon, C., Abas

L. A preparation of pure, quantitated and viable human

platelets: in vivo energy budget and the Pasteur effect.

ASMBM. (Poster presentaion).

1993

24

Whisson, M.E. Developments in platelet storage. Joint

meeting of the ASBT (WA) and HSA (WA). Maragaret River,

Australia. March 1993. (Oral presentation).

Whisson, M.E., Nakhoul, A-M. and Howman. Burnt sugar and

the blood bag. Joint meeting of the ASBT (WA) and HSA

(WA). Maragaret River, Australia. March 1993. (Oral

presentation).

Whisson, M., Nakhoul, A-M., Howman, P., Niu, X. and

Guppy, M. First demonstration of prolongation of

platelet storage by glucose - but is it necessary? Joint

meeting of the HSA and ASBT. Hobart, Australia.

September 1993. (Oral presentation).

Whisson, M., Howman, P., Nakhoul, A-M., Simpson, M. and

Cobain, T. Each platelet bag costs 123ml of plasma: a

second spin could save 64ml. Joint meeting of the HSA and

ASBT. Hobart, Australia. September 1993. (Poster

presentation).

Whisson, M., Howman, P., Nakhoul, A-M. Caramel, the

bogey of the blood bag manufacturer, may be beneficial.

Joint meeting of the HSA and ASBT. Hobart, Australia.

September 1993. (Oral presentation).

1992

25

Dunmow, R., Wilson, D. and Whisson, M. A modified method

for detecting high titre anti-A and anti-B in group O

donors. Joint meeting of the HSA, ASBT and MOGA.

Canberra, Australia. July 1992. (Poster presentation).

Guppy, M., Haig, C., Howman, P. and Nakhoul, A-M. The

energy metabolism of circulating cells. Joint meeting of

the HSA, ASBT and MOGA. Canberra, Australia. July 1992.

(Oral presentation).


Acetate utilisation rates and the effect of glucose-free

plasma in platelet concentrate stored in minimal medium

(MPM). Joint meeting of the HSA, ASBT and MOGA.

Canberra, Australia. July 1992. (Oral presentation).


Facts and fantasy in the development of platelet additive

solutions. Joint meeting of the HSA, ASBT and MOGA.

Canberra, Australia. July 1992. (Oral presentation).

Fisher, B., Whisson, M., Cobain, T. and Wyatt, C. Donor

IgM anti-A with haemolytic transfusion reaction. Joint

meeting of the HSA, ASBT and MOGA. Canberra, Australia.

July 1992. (Poster presentation).

1991

26

Niu, W., Whisson, M.E. and Guppy, M. Endogenous fuels in

starving platelets. Combined Biological Sciences

Meeting. Perth, Australia. (Oral presentation).

Whisson, M.E., Howman, P., Nakhoul, A. and Guppy M. Fuel

requirements of platelets stored in new plasma-free

media. Combined Biological Sciences Meeting. Perth,

Australia. (Oral presentation).

Whisson, M.E. Safe parenteral device design: basic

principles of design and manufacture. Joint meeting of

the ASBT, HSA, HGSA, and ASA. Melbourne, Australia.


Howman, P. and Whisson, M. Use of foreign blood packs

and giving sets: a study in incompatibility and a call

for standardisation. Joint meeting of the ASBT, HSA,

HGSA, and ASA. Melbourne, Australia. (Poster

presentation).

Howman, P. and Whisson, M.E. Closed system red cell

filtering technique allows platelet recovery and use of

banked units. Joint meeting of the ASBT, HSA, HGSA, and

ASA. Melbourne, Australia. (Poster presentation).

Whisson M.E., Nakhoul, A., Howman, P., and Guppy, M.

Platelet storage study using a new plasma-free

‘starvation medium’ and new objective ‘swirl’ assay.

27

Joint meeting of the ASBT, HSA, HGSA, and ASA.

Melbourne, Australia. (Oral presentation).

1990

Guppy, M., Attwood, P.V., and Whisson, M.E. Red cell

storage: what is the right pH? Joint meeting of the HSA,

ASBT, NZSH and RCPA. Christchurch, New Zealand. October



Platelet metabolism and storage: “no added sugar”. Joint

meeting of the HSA, ASBT, NZSH and RCPA. Christchurch,

New Zealand. October 1990. (Oral presentation).

Whisson, M.E., Simpson, M. and Handley, P. Improved

donor care with the ‘ZPR’: a one year study. Joint

meeting of the HSA, ASBT, NZSH and RCPA. Christchurch,

New Zealand. October 1990. (Poster presentation).

Niu, X., Whisson, M.E., Rossetto, M. and Guppy, M. A

method for producing pure preparation of resting

platelets for metabolic studies. Combined Biological

Sciences Meeting. Perth, Australia. (? presentation).

28

Whisson, M.E., Guppy, M., Rossettom M. and Niu, X.

Optimum fuels for platelet storage. Combined Biological

Sciences Meeting. Perth, Australia. (? presentation).

1989

Whisson, M.E., Guppy, M., Sabaratnam, R., Withersm P and

Brand, K. Platelet metabolism, lactate and optimum fuels

for storage. Joint meeting of the HSA and ASBT.

Adelaide, Australia. October 1989. (Oral presentation).

Whisson, M.E. and Simpson, M. The zinc

protoporphyrin/haem ratio (ZPHR) in the selection of

blood donors. Joint meeting of the HSA and ASBT.

Adelaide, Australia. October 1989. (Poster

presentation).

Whisson, M.E. and Armstrong, V. Use of hepatitis B

immunoglobulin (HBIg) for sharps and splash incidents in

W.A. Joint meeting of the HSA and ASBT. Adelaide,

Australia. October 1989. (Poster presentation).

1988

Whisson, M.E., Moffat, M., Sabaratnamm R. and Guppy, M.

Blood storage and imidazole dissociation (-imid): the

blood bag as a hibernating system. 20th ISBT. London,

England.

29

1987

Whisson, M.E., Surveyor, I., Findlay, S. and Jamieson, A.

Indium oxine111 labelling of routine CLX platelet

concentrates for platelet survival and uptake studies.

Combined meeting of the ASBT and HSA Meeting. Hamilton

Island, Queensland.

Thomas, S.E., Petersen, M., Whisson, M.E. and Keller,

A.J. (1987) Selection of immunising cell donors for the

production of anti-D. Combined meeting of the ASBT and

HSA Meeting. Hamilton Island, Queensland.

Guppy, M., Sabaratnam, R. and Whisson M. Blood

metabolism: interacting effects of temperature and pH and

implications as regards to ectotherms and blood storage.

Comparative Physiology Meeting. December 1987.

30

Max CV IIi 09

Documents

Transcript of Max CV IIi 09